Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 21, 2015; 21(11): 3300-3307
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3300
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3300
Figure 1 Flow diagram of patients identified and selected.
CRLM: Colorectal liver metastasis; RFA: Radiofrequency ablation; HNPCC: Hereditary nonpolyposis colorectal cancer.
Figure 2 Recurrence patterns after hepatectomy or radiofrequency ablation for colorectal liver metastasis.
A: Hepatic recurrence; B: Extrahepatic recurrence. RFA: Radiofrequency ablation; CRLM: Colorectal liver metastasis.
Figure 3 Kaplan-Meier survival analysis for disease-free survival and overall survival after hepatectomy or radiofrequency ablation for colorectal liver metastasis.
A: Disease-free survival; B: Overall survival. RFA: Radiofrequency ablation; CRLM: Colorectal liver metastasis.
Figure 4 Kaplan-Meier survival analysis for disease-free survival after hepatectomy or radiofrequency ablation for colorectal liver metastasis according to tumor number and size.
A: Single CRLM; B: Multiple CRLM; C: Size of CRLM (≤ 2 cm); D: Size of CRLM (2 cm < CRLM ≤ 3 cm); E: Single and size of CRLM (≤ 2 cm); F: Multiple or size of CRLM (2 cm < CRLM ≤ 3 cm). RFA: Radiofrequency ablation; CRLM: Colorectal liver metastasis.
-
Citation: Lee H, Heo JS, Cho YB, Yun SH, Kim HC, Lee WY, Choi SH, Choi DW. Hepatectomy
vs radiofrequency ablation for colorectal liver metastasis: A propensity score analysis. World J Gastroenterol 2015; 21(11): 3300-3307 - URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3300.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3300